Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.

ABSTRACT: Introduction:Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity and mortality. A comprehensive description of the global burden of MM is needed to help direct health policy, resource allocation, research, and patient care. Objective:To describe the burden of MM and the availability of effective therapies for 21 world regions and 195 countries and territories from 1990 to 2016. Design and Setting:We report incidence, mortality, and disability-adjusted life-year (DALY) estimates from the Global Burden of Disease 2016 study. Data sources include vital registration system, cancer registry, drug availability, and survey data for stem cell transplant rates. We analyzed the contribution of aging, population growth, and changes in incidence rates to the overall change in in

SUBMITTER: Cowan AJ 

PROVIDER: S-EPMC6143021 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature